Chronic allograft failure: The clinical problem

American Journal of the Medical Sciences

Volumn 313, Issue 5, 1997, Pages 305-309

  Nagano, Hiroaki ^a   Tilney, Nicholas L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Allograft; Antigen Dependent events; Antigen Independent events; Chronic rejection; Risk factor

Indexed keywords

ALLOANTIGEN; CYCLOSPORIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TACROLIMUS;

ALLOGRAFT; ARTICLE; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTION; GRAFT FAILURE; HUMAN; ISCHEMIA; LIVING DONOR; NEPHROTOXICITY; REPERFUSION INJURY; RISK FACTOR;

EID: 0030915659     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40121-1     Document Type: Article

References (48)

1. Matas A, Gillingham K, Sutherland DE. Half-life and risk factors for kidney transplant outcome-importance of death with function. Transplantation. 1993;55:757-61.
2. Tilney NL, Whitely WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection-an undefined conundrum. Transplantation. 1991;52:389-98.
3. Cecka JM, Terasaki PI. The UNOS Scientific Renal Transplant Registry. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1994. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1994:1-18.
4. Hosenpud JD, Norick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: Eleventh official report, 1994. J Heart Lung Transplant. 1994;13:561-70.
5. Starzl TE, Demetri AJ, Van Thiel D. Liver transplantation. N Engl J Med. 1989;321:1014-22.
6. Fellstrom B, Larsson E, Tufveson G. Strategies in chronic rejection of transplanted organs: A current view on pathogenesis, diagnosis, and treatment. Transplant Proc. 1991;23:613.
7. Cramer DV, Chapman FA, Wu G-D, Harnaha JB, Qian S, Makowka L. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation. 1990; 50:554-8.
8. Tilney NL, Chang A, Milford EL, Whitely WD, Lazarus JM, Ramos EL, et al. Ten year experience with cyclosporine as primary immunosuppression in recipient of renal allografts. Ann Surg. 1991;213:42-9.
9. Thorogood J, Van Houwelingen JC, Persijn GG, Van Rood JJ, Zantvoort FA, Schneider GM Th, et al. Factors contributing to long term kidney graft survival in eurotransplant. Transplantation. 1992;54:152-8.
10. Utensky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and predonisone. Circulation. 1987;76:827-34.
11. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation. 1993;55:752-7.
12. Kahan BD. Toward a rational design of clinical trials of immunosuppressive agents in transplantation. Immunol. Rev. 1993;136:29-49.
13. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation Immunol Today. 1994;15:32.
14. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. Transplantation. 1992; 53:550-5.
15. Tullius SG, Heemann UW, Hancock WW, Azuma H, Tilney NL. Long-term kidney isografts develop functional and morphological changes which mimic those of chronic allograft rejection. Ann Surg. 1994;220:425-35.
16. Glassock RJ, Feldman D, Reynolds ES Jr, Dammin GJ, Merrill JP. Human renal isografts: A clinical and pathologic analysis. Medicine (Baltimore). 1968;47:411-54.
17. Tullius SG, Hancock WW, Heemann UW, Azuma H, Tilney NL. Reversibility of chronic renal allograft rejection: Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation. 1994;58:93-9.
18. Van Es A, Hermans J, Van Bockel JH, Persijn GG, Van Hooff JP, Graeff J. Effect of warm ischemic time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes. Transplantation. 1983;36:255-8.
19. Cecka JM, Cho YW, Terasaki PI. Analyses of the UNOS Scientific Renal Transplant Registry at three years - Early events affecting transplant success. Transplantation. 1992; 53:59-64.
20. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Transplantation. 1995;59:565-72.
21. Linas SL, Whittenburg D, Parsons PE, Repine JE. Mild renal ischemia activates primed neutrophiles to cause acute renal failure. Kidney Int. 1992;42:610-6.
22. Yamazaki T, Seko Y, Tamatani T, Miyasaka M, Yagita H, Okumura K, et al. Expression of inter-cellular adhesion molecule-1 in rat hearts with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol. 1993;143:410-8.
23. Schaudies RP, Johnson JP. Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors. Am J Physiol. 1993;264:F523-31.
24. Land W, Schneeberger H, Schleibner S, Illner W-D, Abendroch D, Rutili G, et al. The beneficial effect of human recombinant Superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation. 1994;57:211-7.
25. Border WA, Nobel NA. Mechanisms of disease: Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331:1286-92.
26. Fine LG, Hemmerman MR, Abboud HE. Evolving role of growth factors in the renal response to acute and chronic disease. J Am Soc Nephrol. 1992;2:1163-70.
27. Ploeg RJ. Kidney preservation with UW and Euro-Collins solutions. Transplantation. 1990;49:281-2.
28. Fricker FJ, Griffth BP, Hardesty RI, Trento A, Gold LM, Schmeltz K, et al. Experience in heart transplantation in children. Pediatrics. 1987;79:138-46.
29. Newstead CG, Dyer PA. The influence of increased age and age matching on graft survival after first cadaveric renal transplantation. Transplantation. 1992;54:441-3.
30. Odland MD, Kasiske BL. Kidneys from female donors are at increased risk for chronic allograft rejection. Transplant Proc. 1993;25:912.
31. Yuge J, Cecka JM. Sex and age effects in renal transplantation. In: Terasaki P, ed. Clinical Transplants 1991. Los Angeles, CA: UCLA Tissue Typing Laboratory: 1991:257.
32. Butkus DE, Meyderech EF, Raju SS. Racial differences in the survival of cadeveric renal allografts. Overriding effects of socioeconomics factors. N Engl J Med. 1992;327:840-5.
33. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Wiederhold V, et al. Clinical and laboratory correlation of accelerated coronary artery disease in the cardiac transplant patient. Circulation. 1987;76(suppl 5):V56-61.
34. Adams DH, Karnovsky MJ. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts. Transplant Proc. 1989;21:437-9.
35. Mennander A, Tikkanen MJ, Häisänen-Sokolowski A, Paavonen T, Ustinov J, Häyry P. Effect of hypercholesterolemia in allograft arteriosclerosis. J Heart Lung Transplant. 1993;12:123-32.
36. Brazy PC, Pirsch JD, Belzer FO. Factors affecting renal allograft function in long-term recipients. Am J Kidney Dis. 1992;19:558-66.
37. Myers BD, Sposs J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984;311:699-705.
38. Eich D, Hastillo A, Thompson JA. Hypercholesterolemia in long-term survivors of heart transplantation. J Heart Lung Transplant. 1986;5:377.
39. Norman SJ, Salomon DR, Leelachaikul P, Khan SR, Staples ED, Alexander JA, et al. Acute vascular rejection of the coronary arteries in human heart transplantation: Pathology and correlations with immunosuppression and cytomegalovirus infection. J Heart Lung Transplant. 1991; 10:674-87.
40. Garcia DL, Rennke HG, Brenner BM, Anderson S. Corticosteroid therapy amplifies glomerular injury in rats with renal obliteration. J Clin Invest. 1987;80:867-74.
41. Koskinen PK, Krogerus LA, Nieminen MS, Mattila SP, Häyry P, Lautenschlager IT. Cytomegalovirus infection-associated generalized immune activation in heart allograft recipients: A study of cellular events in peripheral blood and endomyocardial biopsy specimens. Transpl Int. 1994;7:163.
42. Reinke P, Fietze E, Ode-Hakim S, Pr̈osch S, Lippert J, Ewert R, Volk H-D. Late acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet. 1994;344: 1737-8.
43. Fujinami RS, Nelson JA, Walker L, Oldstone MBA. Sequence homology and immunologic cross reactivity of human cytomegalovirus with HDL-DR beta chain: A means for graft rejection and immunosuppression. J Virol. 1988;62:100-5.
44. Beck S, Barrel BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature. 1988;331 269-72.
45. Koskinen PK. Induction of vascular cell adhesion molecule-1 is associated with cytomegalovirus antigenemia in human heart allograft. Transplantation. 1993;56:1103-8.
46. Terasaki PI, Cecka JH, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living-related donors. N Engl J Med. 1995;333:333-6.
47. Dallman M. The cytokine network and regulation of the immune response to organ transplants. Transplant Rev. 1992;6:209-17.
48. Williams TJ, Hellewell PG. Endothelial cell biology. Adhesion molecules involved in the microvascular inflammatory response. American Review of Respiratory Disease. 1992; 146(suppl):S45-50.